DoW Orthopaedic, Clinical Research Award
Defense Health Agency Contracting Activity - DHACA
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- May 21, 2026
- Amount
- Program total $13.6M
- Closes
- Nov 18, 2026
Similar opportunities open now
- DoW Orthopaedic, Applied Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Nov 18, 2026
- DoW Spinal Cord Injury, Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Nov 12, 2026
- DoW Vision, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Nov 12, 2026
- DoW Spinal Cord Injury, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Nov 12, 2026
- DoW Toxic Exposures Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses Nov 19, 2026
Classification and identifiers
- Solicitation number
- HT942526ORPCRA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $13.6M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Orthopaedic Research Program (ORP) Clinical Research Award (CRA) seeks clinical research that evaluates orthopaedic-specific factors and interventions. The ORP intends for research supported by this mechanism to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical care or policy. Applications must address how the proposed research will impact patient care and reduce the burden of orthopaedic injury and sequela. The ORP expects that research findings benefit Service Members, their families, Veterans and the general public. To meet the intent of the award mechanism, applications must specifically address at least one of the FY26 ORP CRA Focus Areas. Distinctive Features: · The CRA offers two research levels. ...